Looking at Expired Children's Medications
In a recent poll, only 1 in 5 parents believed it is unsafe for children to take medicine past its expiration date, while many did not know how to properly dispose medicine.
Pediatric Patients at End of Life Are Often Given Antibiotics
Antibiotics are often administered to pediatric patients at end of life, even in cases without infection.
Long COVID Leads to Lingering Effects in Children
Additional research is needed to fully understand the scope of Long COVID.
Increased Menstrual Cycle Length Tied to COVID-19 Vaccine
In a recent study, participants who had received a COVID-19 vaccine saw an average increase in menstrual cycle length of less than 1 day.
Contraceptive Access Negatively Impacted by COVID-19
In a recent study, it was found that access to contraceptive services declined during the COVID-19 pandemic.
ABX1100 Given Rare Pediatric Drug Designation by FDA
Aro Biotherapeutics’ ABX1100, used to treat Pompe disease, was granted a Rare Pediatric Drug designation by the FDA.
Maternal Vaccination Cut the Risk of COVID-19 Hospitalization for Infants
Infants of fully vaccinated mothers had fewer cases of hospitalization from COVID-19 than those unvaccinated.
Dupilumab Is Safe and Effective for Long-term Use in Kids
Improvements in atopic dermatitis symptoms were seen in children taking dupilumab, with minimal adverse events.
Children Can Do Swabbing for COVID-19 Tests
In a recent study, children were successfully able to self-swab and receive their own COVID-19 test results after basic instructions.
Inflammatory Bowel Disease Treatment Costs Reduced with IFX biosimilar
Although further studies are needed to confirm the long-term effects, recent studies have shown the infliximab biosimilar to be a safe, effective, and cost reducing treatment for inflammatory bowel diseases.
Reducing Anxiety in Children with ADHD Using Atomoxetine
A recent review suggests that atomoxetine can reduce symptoms of anxiety in children and adolescents with ADHD.
What's Coming for Pediatric Atopic Dermatitis
Children with atopic dermatitis will soon have more options for treatment, as clinical trials show promising results.
Xofluza for Pediatric Treatment of Influenza Approved by FDA
Xofluza is now the first single-dose oral medication for influenza approved for children aged less than 12 years.